RARE Drug Development Symposium: Galvanizing Next Steps in Rare Disease Research

What silver linings can we create for rare diseases from the COVID-19 pandemic? Panelists Dr. David Fajgenbaum, Dr. Jeremy Levin, and Dr. Katherine Beaverson discuss the future of rare disease research and why working together holds our best opportunity for hope.